Nalfurafine Hydrochloride

盐酸纳呋拉啡

Report date: 2023/07/11 11:13:57
NME

Base Information

Drug NameNalfurafine Hydrochloride
Drug Alias Namenalfurafina纳呋拉啡盐酸盐纳呋拉啡NalfurafineWinfuran +[12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor agonists
TargetsKappa opioid receptor
Therapy Area/IndicationsPruritusRenal InsufficiencyLiver Diseases
Global Approved IndicationsPruritus
Approved Indications in ChinaPruritus
Original Approved Country/TerritoryJapan
Original Approved Date2009/01/21
Country/TerritoryBulgariaUnited StatesGermany +[6
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesToray Industries Inc
China Registration ClassN/A

Develop Information

Active IndicationsPruritusLiver Diseases
Inactive IndicationsRenal Insufficiency

Other Information

ATC CodeV03AX02
Related LinksWikipediaKEGG